• レポートコード:GIR-22E8923 • 出版社/出版日:GlobalInfoResearch / 2022年5月 • レポート形態:英文、PDF、106ページ • 納品方法:Eメール(2~3営業日) • 産業分類:医薬品 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
パントプラゾール注射剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のパントプラゾール注射剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。 パントプラゾール注射剤市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・40mg、 60mg 用途別セグメントは次のように区分されます。 ・病院、専門クリニック、回復センター 世界のパントプラゾール注射剤市場の主要な市場プレーヤーは以下のとおりです。 ・AuroMedics、Hikma、Pfizer、Sun Pharma、Aristo Pharmaceuticals、Abbot、Wellona Pharma、Taj Pharma、Cipla、Beijing Sihuan Pharm、Reyoung Pharm、Jinzhou Jiutai Pharmaceutical、Shenyang Guangda Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計15章あります。 ・第1章では、パントプラゾール注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なパントプラゾール注射剤メーカーの企業概要、2019年~2022年までのパントプラゾール注射剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なパントプラゾール注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年~2028年までの地域別パントプラゾール注射剤の販売量、売上、成長性を示しています。 ・第5、6章では、2017年~2028年までのパントプラゾール注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのパントプラゾール注射剤市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびパントプラゾール注射剤の産業チェーンを掲載しています。 ・第13、14、15章では、パントプラゾール注射剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):AuroMedics、Hikma、Pfizer、Sun Pharma、Aristo Pharmaceuticals、Abbot、Wellona Pharma、Taj Pharma、Cipla、Beijing Sihuan Pharm、Reyoung Pharm、Jinzhou Jiutai Pharmaceutical、Shenyang Guangda Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年:40mg、 60mg ・用途別分析2017年-2028年:病院、専門クリニック、回復センター ・パントプラゾール注射剤の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ ・パントプラゾール注射剤のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア ・パントプラゾール注射剤のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア ・パントプラゾール注射剤の南米市場規模2017年-2028年:ブラジル、アルゼンチン ・パントプラゾール注射剤の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pantoprazole Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pantoprazole Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Pantoprazole Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 40mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pantoprazole Injection include AuroMedics, Hikma, Pfizer, Sun Pharma, and Aristo Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pantoprazole Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
40mg
60mg
Market segment by Application can be divided into
Hospital
Special Clinic
Recovery Center
The key market players for global Pantoprazole Injection market are listed below:
AuroMedics
Hikma
Pfizer
Sun Pharma
Aristo Pharmaceuticals
Abbot
Wellona Pharma
Taj Pharma
Cipla
Beijing Sihuan Pharm
Reyoung Pharm
Jinzhou Jiutai Pharmaceutical
Shenyang Guangda Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pantoprazole Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pantoprazole Injection, with price, sales, revenue and global market share of Pantoprazole Injection from 2019 to 2022.
Chapter 3, the Pantoprazole Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pantoprazole Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pantoprazole Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pantoprazole Injection.
Chapter 13, 14, and 15, to describe Pantoprazole Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pantoprazole Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pantoprazole Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 40mg
1.2.3 60mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Pantoprazole Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Special Clinic
1.3.4 Recovery Center
1.4 Global Pantoprazole Injection Market Size & Forecast
1.4.1 Global Pantoprazole Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pantoprazole Injection Sales in Volume (2017-2028)
1.4.3 Global Pantoprazole Injection Price (2017-2028)
1.5 Global Pantoprazole Injection Production Capacity Analysis
1.5.1 Global Pantoprazole Injection Total Production Capacity (2017-2028)
1.5.2 Global Pantoprazole Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pantoprazole Injection Market Drivers
1.6.2 Pantoprazole Injection Market Restraints
1.6.3 Pantoprazole Injection Trends Analysis
2 Manufacturers Profiles
2.1 AuroMedics
2.1.1 AuroMedics Details
2.1.2 AuroMedics Major Business
2.1.3 AuroMedics Pantoprazole Injection Product and Services
2.1.4 AuroMedics Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Hikma
2.2.1 Hikma Details
2.2.2 Hikma Major Business
2.2.3 Hikma Pantoprazole Injection Product and Services
2.2.4 Hikma Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Pantoprazole Injection Product and Services
2.3.4 Pfizer Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sun Pharma
2.4.1 Sun Pharma Details
2.4.2 Sun Pharma Major Business
2.4.3 Sun Pharma Pantoprazole Injection Product and Services
2.4.4 Sun Pharma Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Aristo Pharmaceuticals
2.5.1 Aristo Pharmaceuticals Details
2.5.2 Aristo Pharmaceuticals Major Business
2.5.3 Aristo Pharmaceuticals Pantoprazole Injection Product and Services
2.5.4 Aristo Pharmaceuticals Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Abbot
2.6.1 Abbot Details
2.6.2 Abbot Major Business
2.6.3 Abbot Pantoprazole Injection Product and Services
2.6.4 Abbot Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Wellona Pharma
2.7.1 Wellona Pharma Details
2.7.2 Wellona Pharma Major Business
2.7.3 Wellona Pharma Pantoprazole Injection Product and Services
2.7.4 Wellona Pharma Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Taj Pharma
2.8.1 Taj Pharma Details
2.8.2 Taj Pharma Major Business
2.8.3 Taj Pharma Pantoprazole Injection Product and Services
2.8.4 Taj Pharma Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Pantoprazole Injection Product and Services
2.9.4 Cipla Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Beijing Sihuan Pharm
2.10.1 Beijing Sihuan Pharm Details
2.10.2 Beijing Sihuan Pharm Major Business
2.10.3 Beijing Sihuan Pharm Pantoprazole Injection Product and Services
2.10.4 Beijing Sihuan Pharm Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Reyoung Pharm
2.11.1 Reyoung Pharm Details
2.11.2 Reyoung Pharm Major Business
2.11.3 Reyoung Pharm Pantoprazole Injection Product and Services
2.11.4 Reyoung Pharm Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Jinzhou Jiutai Pharmaceutical
2.12.1 Jinzhou Jiutai Pharmaceutical Details
2.12.2 Jinzhou Jiutai Pharmaceutical Major Business
2.12.3 Jinzhou Jiutai Pharmaceutical Pantoprazole Injection Product and Services
2.12.4 Jinzhou Jiutai Pharmaceutical Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shenyang Guangda Pharmaceutical
2.13.1 Shenyang Guangda Pharmaceutical Details
2.13.2 Shenyang Guangda Pharmaceutical Major Business
2.13.3 Shenyang Guangda Pharmaceutical Pantoprazole Injection Product and Services
2.13.4 Shenyang Guangda Pharmaceutical Pantoprazole Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pantoprazole Injection Breakdown Data by Manufacturer
3.1 Global Pantoprazole Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pantoprazole Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pantoprazole Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Pantoprazole Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Pantoprazole Injection Manufacturer Market Share in 2021
3.5 Global Pantoprazole Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pantoprazole Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pantoprazole Injection Market Size by Region
4.1.1 Global Pantoprazole Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Pantoprazole Injection Revenue by Region (2017-2028)
4.2 North America Pantoprazole Injection Revenue (2017-2028)
4.3 Europe Pantoprazole Injection Revenue (2017-2028)
4.4 Asia-Pacific Pantoprazole Injection Revenue (2017-2028)
4.5 South America Pantoprazole Injection Revenue (2017-2028)
4.6 Middle East and Africa Pantoprazole Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pantoprazole Injection Sales in Volume by Type (2017-2028)
5.2 Global Pantoprazole Injection Revenue by Type (2017-2028)
5.3 Global Pantoprazole Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pantoprazole Injection Sales in Volume by Application (2017-2028)
6.2 Global Pantoprazole Injection Revenue by Application (2017-2028)
6.3 Global Pantoprazole Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pantoprazole Injection Sales by Type (2017-2028)
7.2 North America Pantoprazole Injection Sales by Application (2017-2028)
7.3 North America Pantoprazole Injection Market Size by Country
7.3.1 North America Pantoprazole Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Pantoprazole Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pantoprazole Injection Sales by Type (2017-2028)
8.2 Europe Pantoprazole Injection Sales by Application (2017-2028)
8.3 Europe Pantoprazole Injection Market Size by Country
8.3.1 Europe Pantoprazole Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Pantoprazole Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pantoprazole Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Pantoprazole Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Pantoprazole Injection Market Size by Region
9.3.1 Asia-Pacific Pantoprazole Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pantoprazole Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pantoprazole Injection Sales by Type (2017-2028)
10.2 South America Pantoprazole Injection Sales by Application (2017-2028)
10.3 South America Pantoprazole Injection Market Size by Country
10.3.1 South America Pantoprazole Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Pantoprazole Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pantoprazole Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Pantoprazole Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Pantoprazole Injection Market Size by Country
11.3.1 Middle East & Africa Pantoprazole Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pantoprazole Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pantoprazole Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pantoprazole Injection
12.3 Pantoprazole Injection Production Process
12.4 Pantoprazole Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pantoprazole Injection Typical Distributors
13.3 Pantoprazole Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer